Consistent with these changes, immunofluorescence staining confirmed the increased CD8+ and CXCR3+ T cell abundance and colocalisation in sitagliptin-treated tumour tissue; whilst there was no significant change in CD4/CXCR3 colocalisation (Figure 4D). The gene discussed is CXCR3; the disease is neoplasm.